Resvent Medical Technology Co.,Ltd

Resvent Medical Technology Co., Ltd is a global fast-growing solution provider for respiratory health. The company's focus areas include chronic respiratory disease diagnosis & treatment, critical mechanical ventilation, AI and digital healthcare, and intelligent cloud information systems. With a strong emphasis on research and development, Resvent continuously innovates to deliver high-quality medical solutions. The company prides itself on independent innovation, holding over 100 domestic and foreign registered patents and trademarks. Resvent's products have obtained China NMPA, CE, FDA EUA certification, and its integrated medical solutions and customized services have garnered customers from more than 60 countries and regions around the world. Since its establishment in 2015, Resvent has exhibited a commitment to meeting new medical and healthcare challenges by providing high-performance and cost-effective solutions for digital medical and chronic disease management. Moreover, the company prioritizes social responsibility, as evidenced by its proactive assistance during the COVID-19 pandemic, where its products rushed to aid numerous countries in the fight against the epidemic. Resvent's last investment was a Seed Round investment at 01 January 2017, with the participation of WI Harper Group as the investors. Overall, Resvent Medical Technology Co., Ltd stands out as an innovative player in the health care and medical devices industries, with a strong focus on respiratory health and a global footprint.